Archy raises $50M Series C to scale dental AI agents. Archy has raised a $50M Series C led by JMI Equity, with existing investors TCV, Entrée Capital, Bessemer Venture Partners, CRV, and Alven participating. The San Jose dental practice-management company announced the round on September 11, 2026, and said the capital will accelerate AI agents that carry out work across insurance, billing, documentation, scheduling, communication, and practice analytics. The financing matters because Archy is building those agents inside the software already holding the schedule, chart, claim, payment, imaging record, and patient conversation. That creates a different operating proposition from adding a standalone AI tool to an already fragmented dental technology stack. Archy reports that its platform now serves 1,000 practices across 45 states, processes more than $300M in payments annually, and supports millions of patients. Those figures are company-reported, but they show the environment in which the next generation of agents will have to work: live practices where administrative automation touches clinical records, revenue cycles, and patient trust. What happened in Archy's Series C. The $50M Series C introduces JMI Equity as the lead investor and brings back TCV, Entrée Capital, Bessemer Venture Partners, CRV, and Alven. Axios independently corroborated the amount, round, lead, participating firms, and Archy's San Jose base. Archy did not disclose a valuation, detailed security terms, a new board appointment, or a budget-level use-of-proceeds plan. The company tied the financing directly to faster development of AI agents that take on everyday work around a dental appointment. The round follows a $20M Series B led by TCV in October 2025. That financing brought Archy's reported total funding to $47M after a $15M Series A in 2024 and earlier capital, including a $10M announcement in 2022. Adding the Series C to the previously reported total implies approximately $97M in cumulative funding, although Archy did not state that figure in the new announcement. From dental system of record to system of action. Jonathan Rat and Ben Kolin founded Archy in 2021 after Rat helped his dentist wife manage the technology and administrative burden at her practice. Current company materials identify Rat as co-founder and CEO and Kolin as co-founder and CTO. Archy's origin story begins with a familiar vertical-software problem: a practice may look like one business to the patient while its staff moves work across separate systems behind the scenes. Archy built a cloud platform combining scheduling, charting, imaging, payments, patient communication, insurance, billing, and reporting. Its Series C announcement describes the next layer as a "system of action," meaning software that can move work forward instead of only storing information or answering questions. That agent portfolio spans Archy Revenue for claims and collections, Archy Scribe for clinical notes and voice perio charting, Archy Verify for eligibility checks, Archy Connect for communication and scheduling, and an Insight or Intelligence function for answers drawn from practice data. Official product pages present Revenue and Scribe as available, while Verify and Connect remain in development. The distinction keeps the financing story grounded in what exists today and what the new capital is meant to build. Why workflow context matters for dental AI. A generic assistant can produce a plausible answer from a prompt. A dental agent following up on a claim needs the correct patient, appointment, payer response, procedure codes, balance, payment state, and escalation rule. A scribe placing information into a clinical note needs the chart and treatment context, plus a review path that keeps the clinician responsible for the record. That is where an integrated practice-management platform may have an advantage. Archy already sits across the handoffs the agents are meant to automate, so the company can build against shared operational context instead of asking each point tool to reconstruct the practice through integrations. The commercial question is whether that context produces dependable action, not merely a larger feature list. Archy's scale makes that question immediate. The company says it has grown to 130 people and now supports 1,000 practices. Its current homepage also reports 5.2M+ patients served, 35,000+ active users, 60M+ images processed, and 3M+ claims created. These are self-reported metrics rather than audited measures of AI performance, but they define the surface area across which accuracy and escalation will matter. What the $50M changes for Archy. The financing gives Archy more capacity to develop and deploy agents across revenue-cycle work, documentation, insurance verification, patient communication, scheduling, and analytics. It also raises the operational standard the company has to meet as software takes responsibility for more steps inside a practice. Dental administration is full of work that appears routine until an exception arrives. A claim can need human judgment. An eligibility response can be incomplete. A clinical note can require correction. A patient message can shift from scheduling into care. The useful version of automation handles the repeatable work and makes the exception visible to the person qualified to resolve it. For JMI Equity and Archy's returning investors, the Series C is a bet on vertical software moving beyond records and dashboards. If Archy can make its agents accurate, inspectable, and easy for dental teams to supervise, the platform can convert workflow ownership into a deeper operating role. That opportunity is larger than selling one more dental AI feature, but it also places the company's product decisions closer to the financial and clinical consequences of the practices it serves. The broader dental software signal. Dental practices have spent years moving from server-bound systems toward cloud software. Archy's new round finances the next migration: from software that centralizes work to software that carries selected work forward. That shift will pressure both established practice-management systems and AI point solutions. Core platforms will try to use their access to workflow context as an advantage, while specialized tools will need integrations deep enough to act without losing the state of the patient, claim, appointment, or payment. Buyers will care less about which product uses the most ambitious AI language and more about which one removes administrative work without creating a new layer of review and repair. Archy enters that contest with a growing installed base, a new growth-equity lead, and returning investors that have watched the company progress through multiple rounds. The next proof will arrive inside the practice, where the agent has to finish the right task, surface the right exception, and leave the dental team with less work than it had before. DevCuration Data Healthcare AI funding, last 30 days. DevCuration's funding database tracked 14 Healthcare AI rounds totaling $276.4M in disclosed capital over the past 30 days. Recent deals DevCuration covered:

Archy has raised $50 million in Series C funding for its practice-management software targeting independent dental offices, CEO Jonathan Rat told Axios. The company addresses a common challenge faced by smaller dental practices, where nonclinical staff typically handle payments and insurance work manually or outsource these tasks to billing firms. The funding will support Archy's mission to automate administrative processes in dental offices, helping practices streamline operations beyond clinical care.